South Africa has put its roll-out of the Oxford-Astrazeneca vaccine on hold after a study showed “disappointing” results against its new Covid variant.
Scientists say the strain accounts for 90% of new Covid cases in South Africa.
The study, involving around 2,000 people, found the vaccine offered “minimal protection” against mild and moderate cases of covid-19.
Speaking at an online news conference on Sunday, South African Health Minister, Zweli Mkhize said his government would wait for further advice on how best to proceed with the Oxford-Astrazeneca vaccine in light of the findings.
In the meantime, he said, the government will offer vaccines produced by Johnson & Johnson and Pfizer in the coming weeks.
YOU CAN ALSO READ: *South Africa Covid Infections Passes One Million As The Virus Spreads